Judah Frommer
Stock Analyst at Morgan Stanley
(3.61)
# 953
Out of 4,412 analysts
129
Total ratings
55.47%
Success rate
2.7%
Average return
Main Sectors:
33 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLPG Galapagos NV | Maintains: Equal-Weight | $38 | $28.76 | +32.13% | 2 | Apr 22, 2024 | |
| MURA Mural Oncology | Initiates: Overweight | $13 | $3.58 | +263.13% | 1 | Apr 4, 2024 | |
| PROK ProKidney | Assumes: Equal-Weight | $3 | $2.12 | +41.51% | 1 | Mar 7, 2024 | |
| ACLX Arcellx | Initiates: Overweight | $81 | $51.92 | +56.01% | 1 | Mar 7, 2024 | |
| JSPR Jasper Therapeutics | Reiterates: Outperform | $40 | $20.40 | +96.08% | 8 | Aug 14, 2023 | |
| AKLI Akili | Reiterates: Outperform | $4 | $0.25 | +1,532.65% | 3 | Aug 11, 2023 | |
| ABOS Acumen Pharmaceuticals | Reiterates: Outperform | $13 | $3.17 | +310.09% | 5 | Aug 9, 2023 | |
| RNA Avidity Biosciences | Reiterates: Outperform | $30 | $24.36 | +23.15% | 8 | Aug 9, 2023 | |
| STOK Stoke Therapeutics | Reiterates: Outperform | $23 | $12.41 | +85.33% | 5 | Aug 8, 2023 | |
| PTCT PTC Therapeutics | Reiterates: Neutral | $50 | $28.57 | +75.01% | 8 | Jul 20, 2023 | |
| SRPT Sarepta Therapeutics | Reiterates: Neutral | $141 | $128.77 | +9.50% | 13 | Jun 23, 2023 | |
| IKNA Ikena Oncology | Reiterates: Outperform | $13 | $1.30 | +900.00% | 5 | May 16, 2023 | |
| ATAI Atai Life Sciences | Reiterates: Outperform | $9 | $1.93 | +366.32% | 5 | May 12, 2023 | |
| EFTR eFFECTOR Therapeutics | Maintains: Outperform | $175 → $138 | $1.89 | +7,175.13% | 6 | May 10, 2023 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $21 → $22 | $21.99 | +0.05% | 2 | Apr 3, 2023 | |
| CADL Candel Therapeutics | Maintains: Outperform | $8 → $7 | $6.39 | +9.55% | 3 | Mar 31, 2023 | |
| FULC Fulcrum Therapeutics | Downgrades: Neutral | $11 → $8 | $7.14 | +12.04% | 5 | Mar 10, 2023 | |
| INBX Inhibrx | Reiterates: Outperform | $46 | $34.06 | +35.06% | 4 | Mar 7, 2023 | |
| ESPR Esperion Therapeutics | Upgrades: Neutral | $6.5 → $7 | $1.90 | +268.42% | 6 | Mar 7, 2023 | |
| QURE uniQure | Maintains: Outperform | $51 → $55 | $4.53 | +1,114.13% | 3 | Feb 28, 2023 | |
| INSM Insmed | Reiterates: Outperform | $46 | $24.80 | +85.48% | 1 | Feb 24, 2023 | |
| ACI Albertsons Companies | Initiates: Outperform | n/a | $20.13 | - | 1 | Jul 21, 2020 | |
| FIVE Five Below | Maintains: Outperform | n/a | $150.08 | - | 6 | Jun 10, 2020 | |
| OLLI Ollie's Bargain Outlet Holdings | Downgrades: Neutral | n/a | $74.46 | - | 4 | May 26, 2020 | |
| USFD US Foods Holding | Maintains: Outperform | n/a | $51.35 | - | 3 | May 6, 2020 | |
| SYY Sysco | Maintains: Outperform | n/a | $77.07 | - | 3 | May 6, 2020 | |
| SFM Sprouts Farmers Market | Maintains: Neutral | n/a | $66.98 | - | 1 | May 6, 2020 | |
| KR The Kroger Co. | Maintains: Neutral | n/a | $55.49 | - | 6 | Apr 29, 2020 | |
| PFGC Performance Food Group | Reinstates: Outperform | n/a | $68.85 | - | 2 | Apr 20, 2020 | |
| DLTR Dollar Tree | Maintains: Outperform | n/a | $121.74 | - | 5 | Mar 5, 2020 | |
| BJ BJ's Wholesale Club Holdings | Initiates: Outperform | n/a | $76.65 | - | 1 | Feb 13, 2020 | |
| COST Costco | Initiates: Neutral | n/a | $729.18 | - | 1 | Feb 13, 2020 | |
| DG Dollar General | Maintains: Neutral | n/a | $142.07 | - | 1 | Jun 1, 2018 |
Galapagos NV
Apr 22, 2024
Maintains: Equal-Weight
Price Target: $38
Current: $28.76
Upside: +32.13%
Mural Oncology
Apr 4, 2024
Initiates: Overweight
Price Target: $13
Current: $3.58
Upside: +263.13%
ProKidney
Mar 7, 2024
Assumes: Equal-Weight
Price Target: $3
Current: $2.12
Upside: +41.51%
Arcellx
Mar 7, 2024
Initiates: Overweight
Price Target: $81
Current: $51.92
Upside: +56.01%
Jasper Therapeutics
Aug 14, 2023
Reiterates: Outperform
Price Target: $40
Current: $20.40
Upside: +96.08%
Akili
Aug 11, 2023
Reiterates: Outperform
Price Target: $4
Current: $0.25
Upside: +1,532.65%
Acumen Pharmaceuticals
Aug 9, 2023
Reiterates: Outperform
Price Target: $13
Current: $3.17
Upside: +310.09%
Avidity Biosciences
Aug 9, 2023
Reiterates: Outperform
Price Target: $30
Current: $24.36
Upside: +23.15%
Stoke Therapeutics
Aug 8, 2023
Reiterates: Outperform
Price Target: $23
Current: $12.41
Upside: +85.33%
PTC Therapeutics
Jul 20, 2023
Reiterates: Neutral
Price Target: $50
Current: $28.57
Upside: +75.01%
Sarepta Therapeutics
Jun 23, 2023
Reiterates: Neutral
Price Target: $141
Current: $128.77
Upside: +9.50%
Ikena Oncology
May 16, 2023
Reiterates: Outperform
Price Target: $13
Current: $1.30
Upside: +900.00%
Atai Life Sciences
May 12, 2023
Reiterates: Outperform
Price Target: $9
Current: $1.93
Upside: +366.32%
eFFECTOR Therapeutics
May 10, 2023
Maintains: Outperform
Price Target: $175 → $138
Current: $1.89
Upside: +7,175.13%
NewAmsterdam Pharma Company
Apr 3, 2023
Maintains: Outperform
Price Target: $21 → $22
Current: $21.99
Upside: +0.05%
Candel Therapeutics
Mar 31, 2023
Maintains: Outperform
Price Target: $8 → $7
Current: $6.39
Upside: +9.55%
Fulcrum Therapeutics
Mar 10, 2023
Downgrades: Neutral
Price Target: $11 → $8
Current: $7.14
Upside: +12.04%
Inhibrx
Mar 7, 2023
Reiterates: Outperform
Price Target: $46
Current: $34.06
Upside: +35.06%
Esperion Therapeutics
Mar 7, 2023
Upgrades: Neutral
Price Target: $6.5 → $7
Current: $1.90
Upside: +268.42%
uniQure
Feb 28, 2023
Maintains: Outperform
Price Target: $51 → $55
Current: $4.53
Upside: +1,114.13%
Insmed
Feb 24, 2023
Reiterates: Outperform
Price Target: $46
Current: $24.80
Upside: +85.48%
Albertsons Companies
Jul 21, 2020
Initiates: Outperform
Price Target: n/a
Current: $20.13
Upside: -
Five Below
Jun 10, 2020
Maintains: Outperform
Price Target: n/a
Current: $150.08
Upside: -
Ollie's Bargain Outlet Holdings
May 26, 2020
Downgrades: Neutral
Price Target: n/a
Current: $74.46
Upside: -
US Foods Holding
May 6, 2020
Maintains: Outperform
Price Target: n/a
Current: $51.35
Upside: -
Sysco
May 6, 2020
Maintains: Outperform
Price Target: n/a
Current: $77.07
Upside: -
Sprouts Farmers Market
May 6, 2020
Maintains: Neutral
Price Target: n/a
Current: $66.98
Upside: -
The Kroger Co.
Apr 29, 2020
Maintains: Neutral
Price Target: n/a
Current: $55.49
Upside: -
Performance Food Group
Apr 20, 2020
Reinstates: Outperform
Price Target: n/a
Current: $68.85
Upside: -
Dollar Tree
Mar 5, 2020
Maintains: Outperform
Price Target: n/a
Current: $121.74
Upside: -
BJ's Wholesale Club Holdings
Feb 13, 2020
Initiates: Outperform
Price Target: n/a
Current: $76.65
Upside: -
Costco
Feb 13, 2020
Initiates: Neutral
Price Target: n/a
Current: $729.18
Upside: -
Dollar General
Jun 1, 2018
Maintains: Neutral
Price Target: n/a
Current: $142.07
Upside: -